From 2006-2008, he was Chief Medical Officer and Vice President of Clinical Affairs at Napo Pharmaceuticals, where he co-authored the two-stage pivotal adaptive trial design leading to approval of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback